tiprankstipranks
Mirati Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe FlyMirati Therapeutics downgraded to Neutral from Buy at Citi
4M ago
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
PremiumThe Fly
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
5M ago
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
PremiumThe Fly
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
5M ago
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
PremiumPress ReleasesMirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
6M ago
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Mirati Therapeutics receives MHRA approval for KRAZATI
PremiumThe Fly
Mirati Therapeutics receives MHRA approval for KRAZATI
6M ago
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe FlyWilliam Blair healthcare/biotech analysts hold analyst/industry conference call
6M ago
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe Fly
William Blair healthcare/biotech analysts hold analyst/industry conference call
6M ago
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
PremiumThe Fly
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100